Tilray Brands (TLRY)
(Delayed Data from NSDQ)
$1.63 USD
+0.04 (2.52%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $1.62 -0.01 (-0.61%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.63 USD
+0.04 (2.52%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $1.62 -0.01 (-0.61%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth C Momentum D VGM
Zacks News
Company News For Dec 19, 2018
by Zacks Equity Research
Companies In The News Are: CBS,BA,DRI,TLRY,NVS
What's In Store for GE in 2019? & Tuesday's Trending Stocks: TLRY, JNJ, ORCL
by Ryan McQueeney
Ryan McQueeney recaps news involving the U.S. housing market, Tilray, Johnson & Johnson, and Oracle. Later, the host provides an outlook for General Electric stock in 2019.
Tilray, Inc. (TLRY) Stock Moves -0.52%: What You Should Know
by Zacks Equity Research
Tilray, Inc. (TLRY) closed at $75.13 in the latest trading session, marking a -0.52% move from the prior day.
4 Reasons Why Pot Stocks & ETF Could Be on a High in 2019
by Sanghamitra Saha
These are the factors that could send marijuana stocks and ETF high in 2019.
Why Tilray (TLRY) Could Be Positioned for a Slump
by Zacks Equity Research
Tilray (TLRY) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.
Are There Any Dividend-Paying Cannabis Stocks?
by Ryan McQueeney
Cannabis stocks have been one of the investing world's top stories in 2018, but for many, these speculative plays are far too unpredictable. Are there any stable, dividend-paying marijuana stocks to buy right now?
Tilray, Inc. (TLRY) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Tilray, Inc. (TLRY) closed the most recent trading day at $102.94, moving +0.48% from the previous trading session.
Options Traders Expect Huge Moves in Tilray (TLRY) Stock
by Zacks Equity Research
Tilray (TLRY) needs investors to pay close attention to the stock based on moves in the options market lately.
Legal Pot Shops & Likely IPOs: Is Hemp the Next Big Thing?
by Nitish Marwah
Increasing tolerance and gradual legalization of marijuana has been an increasing trend across America.
Top and Flop ETFs of Last Week
by Sanghamitra Saha
Inside the winning and losing ETFs of the last week.
What Went Wrong With the Marijuana ETF on Wednesday?
by Sanghamitra Saha
Downbeat earnings have weighed on the marijuana ETF lately. Should you buy the dip or wait on the sidelines?
Cannabis Stocks Reporting Earnings & News from HD, AAPL, TSN
by Ryan McQueeney
Ryan McQueeney discusses the latest trade war developments and recaps earnings results from Home Depot and Tyson Foods. He also touches on Apple's supplier concerns. Later, the host chats with Dave Bartosiak about the marijuana stocks reporting earnings this week.
Cronos (CRON) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Cronos' (CRON) third-quarter results are likely benefit from the company's collaboration initiatives to become one of the most promising cannabis company.
Tilray (TLRY) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
We expect investors to focus on Tilray's (TLRY) pipeline updates when it reports third-quarter results.
The Earnings Charts of 3 Top Cannabis Stocks
by Tracey Ryniec
The cannabis stocks are hot but will their earnings reports be too?
The Zacks Analyst Blog Highlights: Tilray, Walmart and NVIDIA
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Tilray, Walmart and NVIDIA
Upcoming Earnings to Watch: TLRY, WMT, NVDA
by Ryan McQueeney
U.S. stocks fell sharply in morning trading, as concerns about slumping oil prices, a hotter-than-expected PPI, and a more hawkish Fed cooled Wall Street's post-election bullishness. Investors will now turn to the last wave of Q3 earnings reports for clues on what is next for this market
The Zacks Analyst Blog Highlights: Tilray, Canopy Growth, Cronos and ETFMG Alternative Harvest
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Tilray, Canopy Growth, Cronos and ETFMG Alternative Harvest
Why Marijuana Stocks & ETF Soared Today
by Neena Mishra
Pot stocks soared today as Jeff Sessions' exit and midterm elections have created a more favorable political environment for the industry.
Cronos (CRON) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Investors will focus on pipeline progress and updates when Cronos (CRON) reports third-quarter results.
Tilray, Inc. (TLRY) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Tilray, Inc. (TLRY) closed at $100.98 in the latest trading session, marking a +1.5% move from the prior day.
Is A Disappointment in Store for Tilray (TLRY) Q3 Earnings?
by Zacks Equity Research
Investors will focus on pipeline progress and updates when Tilray (TLRY) reports third-quarter results.
Tilray, Inc. (TLRY) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Tilray, Inc. (TLRY) closed at $90.41 in the latest trading session, marking a -0.3% move from the prior day.
The Zacks Analyst Blog Highlights: Tilray, Cronos, Canopy Growth, GW Pharmaceuticals and Constellation Brands
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Tilray, Cronos, Canopy Growth, GW Pharmaceuticals and Constellation Brands
Tilray, Inc. (TLRY) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Tilray, Inc. (TLRY) closed at $120.79, marking a -1.48% move from the previous day.